Uncategorized

Roche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024

Roche introduces navify Analytics, its suite of cloud-based solutions that provide actionable insights to optimise operational and financial outcomes in laboratories and point of care settings.

Roche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024 Read More »

GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ® Gene Therapy at NANOS 2024

​​​​​​​GenSight Biologics announced initial results of new meta-analyses in Leber Hereditary Optic Neuropathy, which show those treated with LUMEVOQ® gene therapy experienced a rate of visual recovery greater than that of idebenone-treated patients and untreated patients.

GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ® Gene Therapy at NANOS 2024 Read More »

Scroll to Top